Partnering Goes Live in
- 00Days
- 00Hrs
- 00Mins
- 00Secs
RNA breakthroughs, Case Studies and Partnerships
September 10-11, 2025Thomas M. Menino Convention & Exhibition Center Peter BerglundCSO at HDT BioSpeaker
Profile
Dr. Berglund has over 25 years of experience in vaccine develop. As the original inventor of RNA vaccination he studied immune response, memory and protection against viral infections and cancers. Previously, he was Executive Director of Research at Immune Design where he advanced products from discovery through late stage clinical trials. He headed up vaccines at Liquidia Technologies and vaccine discovery at AlphaVax. In those roles he has advanced numerous products into clinical trials. He is currently CSO at HDT Bio, a Seattle Biotech developing RNA-based vaccines and therapies.
Agenda Sessions
CMC & Scaling Workshop
, 4:10pmView Session